Teva Recalls Cabergoline Tablets Due to Impurity Specification Failure
Teva Pharmaceuticals is recalling 13,232 bottles of Cabergoline 0.5 mg tablets because the product may not meet impurity specifications over its shelf life.
- Product
- CABERGOLINE — CABERGOLINE (CABERGOLINE)
- Category
- Drug
- Distribution
- Distributed nationwide